Restraints are shown on the lethal injection table in the execution chamber at the Utah ... drug but one that undercut legal arguments from Honie’s attorneys against using an untested cocktail.
Utah spent more than a quarter ... and filed a lawsuit challenging an untested three-drug combination prison officials initially planned to use in his execution. None of these efforts were ...
Restraints are shown on the lethal injection table in the execution ... expensive drug but one that undercut legal arguments from Honie’s attorneys against using an untested cocktail. How a law passed ...
"When those drug shipments come up Interstate 15, a lot of times they'll continue up into Utah, to Montana, into Canada, and the places like Alberta," Gillespie said. "Or they'll make an eastbound ...
Most of that cost came from purchasing the pentobarbital used in the execution. Utah’s first execution in 14 years: Recounting Taberon Honie’s final moments Other costs include paying for ...
Communities across Utah are coming together to remember those who have died by drug overdose, paying tribute to this year’s theme: “Together we can.” According to Utah State University ...
The Utah Department of Corrections ... "Personnel and overtime" used to staff the execution. The state had originally planned on using multi-drug combination of ketamine, fentanyl and potassium ...
The funds to pay for the execution come from the Utah Department of Corrections general budget. The department does not receive any special additional funds to carry out a death sentence. The total ...
I love you all. Take care.” Honie’s execution was the first in the State of Utah in 14 years. The last execution was of Ronnie Lee Gardner, which took place on June 18, 2010, via firing squad.
A large geological feature in southern Utah known as the "Double Arch," the "Hole in the Roof" and sometimes the "Toilet Bowl" has collapsed, National Park Service officials said Friday.
(Reuters) - Merck has stopped two separate late-stage studies of its immunotherapy Keytruda in patients with skin and lung cancers, the company said on Thursday, marking the latest set of trial ...